July 27, 2026Circulation
Cardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“In summary, the 2026 Guideline for CKM syndrome delivers a contemporary, cohesive roadmap that unifies prevention, early detection, and evidence-based therapies, all bolstered by cross-disciplinary collaboration. This approach is essential for optimizing care for individuals with interconnected cardiometabolic conditions within complex socioenvironmental contexts.”
DCDr. Chiadi E. NdumeleChair of the guideline writing committee
“This guideline calls for earlier screening and care, focusing on prevention and coordinated action to reduce the risk of cardiovascular disease before serious complications develop or a major cardiac event occurs.”
DMDr. Mark D. Huffman
“The 2026 Cardiovascular-Kidney-Metabolic (CKM) Syndrome Guideline is an important step toward addressing the large and growing burden of CKM syndrome seen commonly in clinical practice. The CKM Syndrome Guideline synthesizes the latest evidence for clinicians to effectively screen, diagnose, and manage CKM syndrome.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Brewer et al. (2026) studied this question.